AbbVie Inc.

ABBV

Pharmaceutical preparations

Last filing · Quarter 2 · Jun 30, 2026

Financial Statements Ratios

29 more quarters with Pro

AbbVie Inc. back to 2013, every line as filed.

Create a free account

USD ($) $ in Millions, shares in Millions	Jun 30, 2026	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015	Sep 30, 2014	Jun 30, 2014	Mar 31, 2014	Sep 30, 2013	Jun 30, 2013	Mar 31, 2013
Net revenues	$ 16,990	$ 15,002	$ 15,776	$ 15,423	$ 13,343	$ 14,460	$ 14,462	$ 12,310	$ 13,927	$ 13,865	$ 12,225	$ 14,812
Cost of products sold	4,291	4,218	5,304	4,346	4,002	4,212	4,202	4,094	6,485	4,240	3,986	5,022
Net sales	-	-	-	-	-	-	-	-	-	-	-	-
Selling, general and administrative	3,632	3,578	3,569	3,253	3,293	4,205	3,377	3,315	3,372	3,268	3,039	3,304
Research and development	2,344	2,472	2,319	2,131	2,067	2,130	1,948	1,939	1,723	1,733	2,292	1,614
Acquired IPR&D and milestones	291	744	2,680	823	248	82	937	164	66	280	150	40
Other operating income	0	-	0	24	-	0	0	0	0	(169)	(10)	229
Other expense	-	-	-	-	-	-	-	-	-	-	-	-
Total operating costs and expenses	10,558	11,012	13,872	10,529	9,610	10,629	10,464	9,512	11,646	9,352	9,457	10,209
Operating earnings	6,432	3,990	1,904	4,894	3,733	3,831	3,998	2,798	2,281	4,513	2,768	4,603
Interest expense, net	679	645	667	678	627	591	506	453	398	454	454	497
Net foreign exchange loss (gain)	-	-	20	23	4	(3)	1	4	25	37	35	36
Other expense, net	1,475	2,306	503	2,639	1,441	1,159	1,345	586	(95)	1,412	1,804	(330)
Earnings before income tax expense	4,278	1,039	714	1,554	1,661	2,084	2,146	1,755	1,953	2,610	475	4,400
Income tax expense	662	342	526	613	372	520	773	383	172	583	234	448
Net earnings	3,616	697	188	941	1,289	1,564	1,373	1,372	1,781	2,027	241	3,952
Net earnings attributable to noncontrolling interest	3	2	2	3	3	3	3	3	3	3	2	3
Net earnings attributable to AbbVie Inc.	$ 3,613	$ 695	$ 186	$ 938	$ 1,286	$ 1,561	$ 1,370	$ 1,369	$ 1,778	$ 2,024	$ 239	$ 3,949
Per share data
Basic earnings per share (in dollars per share)	$ 2.04	$ 0.39	$ 0.10	$ 0.52	$ 0.72	$ 0.88	$ 0.77	$ 0.77	$ 1.00	$ 1.14	$ 0.13	$ 2.22
Diluted earnings per share (in dollars per share)	2.03	0.39	0.10	0.52	0.72	0.88	0.77	0.77	1.00	1.14	0.13	2.21
Cash dividends declared per common share (in dollars per share)	-	-	-	-	-	-	-	-	-	-	-	-
Weighted-average basic shares outstanding (in shares)	1,769	1,770	1,769	1,768	1,768	1,769	1,768	1,769	1,767	1,767	1,770	1,771
Weighted-average diluted shares outstanding (in shares)	1,771	1,774	1,772	1,771	1,772	1,772	1,771	1,773	1,771	1,771	1,776	1,776